Facebook
Twitter
LinkedIn
ForwardGWEP - Opioid Use in Older Adults
About SETxGWEP
The South East Texas Geriatric Workforce Enhancement Program (SETxGWEP), was funded in 2019 by the United States’ Health Resources Services Administration to prepare the Southeast Texas region with the training and resources to address the specific concerns of aging adults and their caregivers. To learn more about the program, please visit https://setxgwep.org/.
Needs Statement
With the growing opioid pandemic, there is a need to educate prescribers on appropriate utilization of opioids in their care of elderly. There is a need to familiarize physicians with the Texas State code requirements regarding proper screening and pain management contracts.
South East Texas Geriatric Workforce Enhancement Program (SETxGWEP) training promotes the integration of innovative geriatrics approaches and education in care settings that serve older adults to address the training gap in responding to the unique care considerations of older adults.
Target Audience
Physicians, nurse practitioners, pharmacists, social workers, and other healthcare professionals that care for older adults.
EDUCATIONAL METHODS
Lecture
EVALUATION
Evaluation by questionnaire will address program content, presentation, and possible bias.
Learning Objectives
At the conclusion of this activity, the participant will be able to:
- Introduce the utilization of screening tools in chronic pain patients.
- Review the prescription drug monitoring program and how it should be utilized as part of a comprehensive patient work up.
- Discuss the physician-patient pain treatment agreements and how they should be utilized in practice.
- Incorporate the comprehensive pain management requirements set forth in the Texas Administrative Code.
METHOD OF PARTICIPATION
This activity is in an online video module format and includes a two-part didactic presentation.
To receive a certificate you should:
- View the presentation in this enduring material.
- Complete and submit the evaluation form.
- The estimated time to complete this activity, including review of the materials, is 2.00 hour(s).
TERM OF APPROVAL
March 2021 through March 2023. Original release date: March 2021
DISCLAIMER
This activity is designed for use by healthcare professionals for educational purposes only. Information and opinion offered by the contributors represent their viewpoints. Conclusions drawn by the participant should be derived from careful consideration of all available scientific information. Prescription information and use of medical devices should be undertaken only after confirmation of information by consulting the FDA-approved uses and information.
Baylor College of Medicine makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Links are provided to other Internet sites solely for the convenience of users. Once you link to another site, you are subject to the site's terms and conditions of use including copyright and licensing restrictions.
DRUG/DEVICE STATUS DISCLOSURE
Some drugs/devices identified during this activity may have United States Food and Drug Administration (FDA) clearance for specific purposes only or for use in restricted research settings. The FDA has stated that it is the responsibility of the individual physician to determine the FDA status of each drug or device that he/she wishes to use in clinical practice and to use the products in compliance with applicable law.
Baylor College of Medicine requires that all faculty/presenters disclose an unlabeled use or investigational use of pharmaceutical and medical device products, and provide adequate scientific and clinical justification for such use. Physicians are urged to fully review all the available data on products or procedures before using them to treat patients.
DISCLOSURE POLICY
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME’s validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
FACULTY
Julianna Fernandez, Pharm.D., B.C.P.S., B.C.G.P. - Activity Director & Presenter
Clinical Associate Professor
University of Houston College of Pharmacy
Disclosure: Nothing to disclose
Nancy Ordonez, Pharm.D. - Activity Director & Presenter
Clinical Associate Professor
University of Houston College of Pharmacy
Disclosure: Nothing to disclose
Kathryn Agarwal, M.D. - Planning Committee
Assistant Professor of Medicine
Baylor College of Medicine
Disclosure: Nothing to disclose
Elizabeth Brierre, M.S.N.- Planning Committee
Assistant Professor
Baylor College of Medicine
Disclosure: Nothing to disclose
LaToya Shields, B.S.W., M.P.A.- Planning Committee & Presenter
Manager
The Council on Recovery
Disclosure: Nothing to disclose
Janice Sparks, Ph.D, C.R.C.R.- Planning Committee & Presenter
Senior Staff Analyst
Houston Health Department
Disclosure: Nothing to disclose
PEER REVIEWER
In March 2021, this continuing medical education online enduring activity was reviewed by: Anita Major, M.D. To ensure the continued scientific relevance of this enduring material, its content will be reviewed again in April 2023
Anita Major, M.D.
Assistant Professor
Baylor College of Medicine
Disclosure: Nothing to disclose
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Baylor College of Medicine designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been designated by Baylor College of Medicine for 2.00 credits of education in medical ethics and/or professional responsibility.
This activity has been designated by Baylor College of Medicine for 2.00 credits of education in pain management and the prescription of opioids.
Baylor College of Medicine, Division of Continuing Professional Development (License Number 7270) is an approved continuing education provider for Social Workers through the Texas State Board of Social Worker Examiners. This activity has been approved for 2.00 continuing education units.
Available Credit
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Ethics
- 2.00 Pain Management
- 2.00 Participation
- 2.00 Social Work